Cargando…
Response to: Comment on “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients”
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379871/ https://www.ncbi.nlm.nih.gov/pubmed/30867847 http://dx.doi.org/10.1155/2019/2520302 |
| _version_ | 1783396204548194304 |
|---|---|
| author | Aldunate, Fabián Echeverría, Natalia Chiodi, Daniela López, Pablo Sánchez-Cicerón, Adriana Fajardo, Alvaro Soñora, Martín Cristina, Juan Hernández, Nelia Moreno, Pilar |
| author_facet | Aldunate, Fabián Echeverría, Natalia Chiodi, Daniela López, Pablo Sánchez-Cicerón, Adriana Fajardo, Alvaro Soñora, Martín Cristina, Juan Hernández, Nelia Moreno, Pilar |
| author_sort | Aldunate, Fabián |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6379871 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63798712019-03-13 Response to: Comment on “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients” Aldunate, Fabián Echeverría, Natalia Chiodi, Daniela López, Pablo Sánchez-Cicerón, Adriana Fajardo, Alvaro Soñora, Martín Cristina, Juan Hernández, Nelia Moreno, Pilar Dis Markers Letter to the Editor Hindawi 2019-02-05 /pmc/articles/PMC6379871/ /pubmed/30867847 http://dx.doi.org/10.1155/2019/2520302 Text en Copyright © 2019 Fabián Aldunate et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Aldunate, Fabián Echeverría, Natalia Chiodi, Daniela López, Pablo Sánchez-Cicerón, Adriana Fajardo, Alvaro Soñora, Martín Cristina, Juan Hernández, Nelia Moreno, Pilar Response to: Comment on “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients” |
| title | Response to: Comment on “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients” |
| title_full | Response to: Comment on “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients” |
| title_fullStr | Response to: Comment on “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients” |
| title_full_unstemmed | Response to: Comment on “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients” |
| title_short | Response to: Comment on “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients” |
| title_sort | response to: comment on “pretreatment hepatitis c virus ns5a/ns5b resistance-associated substitutions in genotype 1 uruguayan infected patients” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379871/ https://www.ncbi.nlm.nih.gov/pubmed/30867847 http://dx.doi.org/10.1155/2019/2520302 |
| work_keys_str_mv | AT aldunatefabian responsetocommentonpretreatmenthepatitiscvirusns5ans5bresistanceassociatedsubstitutionsingenotype1uruguayaninfectedpatients AT echeverrianatalia responsetocommentonpretreatmenthepatitiscvirusns5ans5bresistanceassociatedsubstitutionsingenotype1uruguayaninfectedpatients AT chiodidaniela responsetocommentonpretreatmenthepatitiscvirusns5ans5bresistanceassociatedsubstitutionsingenotype1uruguayaninfectedpatients AT lopezpablo responsetocommentonpretreatmenthepatitiscvirusns5ans5bresistanceassociatedsubstitutionsingenotype1uruguayaninfectedpatients AT sanchezciceronadriana responsetocommentonpretreatmenthepatitiscvirusns5ans5bresistanceassociatedsubstitutionsingenotype1uruguayaninfectedpatients AT fajardoalvaro responsetocommentonpretreatmenthepatitiscvirusns5ans5bresistanceassociatedsubstitutionsingenotype1uruguayaninfectedpatients AT sonoramartin responsetocommentonpretreatmenthepatitiscvirusns5ans5bresistanceassociatedsubstitutionsingenotype1uruguayaninfectedpatients AT cristinajuan responsetocommentonpretreatmenthepatitiscvirusns5ans5bresistanceassociatedsubstitutionsingenotype1uruguayaninfectedpatients AT hernandeznelia responsetocommentonpretreatmenthepatitiscvirusns5ans5bresistanceassociatedsubstitutionsingenotype1uruguayaninfectedpatients AT morenopilar responsetocommentonpretreatmenthepatitiscvirusns5ans5bresistanceassociatedsubstitutionsingenotype1uruguayaninfectedpatients |